首页> 外国专利> COMBINED AEROSOL PREPARATION BASED ON SALMETEROL AND FLUTICASONE FOR TREATING DISEASES OF THE RESPIRATORY ORGANS

COMBINED AEROSOL PREPARATION BASED ON SALMETEROL AND FLUTICASONE FOR TREATING DISEASES OF THE RESPIRATORY ORGANS

机译:基于沙美特罗和氟替卡松的气雾剂联合治疗呼吸器官疾病

摘要

The invention relates to medicine and to the pharmaceutical industry and concerns the composition of a preparation of a highly effective pharmaceutical substance and auxiliary substances which enable the formation of a fine-particle aerosol for the purpose of penetrating into the bronchi and alveoli of the lungs. An inhalable composition in the form of an aerosol for treating diseases of the respiratory organs contains salmeterol or salmeterol xinafoate, fluticasone or fluticasone propionate, a propellant modifier in the form of perfluorodecalin, and a propellant, selected from 1,1,1,4 tetrafluoroethane (HFA-134a) and/or 1,1,1,2,3,3,3-heptafluoropropane (HFA-227ea).
机译:本发明涉及药物和制药工业,涉及一种高效药物和辅助物质的制剂的组成,所述药物和辅助物质能够形成细粒气雾剂,以渗透到肺的支气管和肺泡中。 。用于治疗呼吸器官疾病的气雾剂形式的可吸入组合物包含沙美特罗或沙美特罗西那福酯,氟替卡松或丙酸氟替卡松,全氟萘烷形式的推进剂改性剂以及选自1,1,1,4四氟乙烷的推进剂(HFA-134a)和/或1,1,1,2,3,3,3-七氟丙烷(HFA-227ea)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号